FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to hepatobiliary surgery and oncology, and is intended to predict the survival of patients with intrahepatic cholangiocellular carcinoma (ICC) in the long-term period after surgical treatment. To do this, the following factors are determined in the postoperative period (F): the age of the patient; the presence of invasion of the liver capsule; the presence of metastases in regional lymph nodes; the radical nature of the operation; the presence of perineural invasion; the presence of mutations in the IDH1, KRAS and MET genes; followed by a scoring of the obtained indicators, the sum of which makes a conclusion about a favorable prognosis with a survival of 36 months or more or an unfavorable prognosis with a survival of less than 36 months.
EFFECT: invention provides highly informative prognosis in relation to the overall survival of this category of patients, which, in turn, will allow optimizing therapy.
1 cl, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING SURVIVAL IN PATIENTS WITH PORTAL CHOLANGIOCARCINOMA AFTER SURGICAL TREATMENT | 2017 |
|
RU2653810C1 |
A METHOD FOR PREDICTING GENERAL SURVIVABILITY IN PATIENTS WITH A CLOTHKIN TUMOR AFTER SURGICAL TREATMENT | 2016 |
|
RU2617183C1 |
METHOD FOR DETERMINING SURVIVAL IN PATIENTS WITH PROXIMAL BILE DUCT TUMORS DURING PREOPERATIVE STAGE | 2018 |
|
RU2678472C1 |
METHOD OF DETERMINATION OF SURVIVAL IN PATIENTS WITH PORTAL CHOLANGIOCARCINOMA | 2018 |
|
RU2666208C1 |
METHOD OF PREDICTING HEMATOGENOUS METASTASIS OF COLON CANCER AFTER COMBINED TREATMENT | 2023 |
|
RU2797845C1 |
METHOD FOR PRE-OPERATIVE DETERMINATION OF PERITONEAL CARCINOSIS PROBABILITY IN PATIENTS WITH PORTAL CHOLANGIOCARCINOMA | 2016 |
|
RU2625898C1 |
METHOD FOR PREDICTION OF FIVE-YEAR SURVIVAL RATE OF PATIENTS IN SURGICAL MANAGEMENT OF RECURRENT NON-GENERALIZED RESECTABLE ORAL CANCER | 2024 |
|
RU2823470C2 |
METHOD FOR ASSESSING RISK OF PROGRESSION OF METASTATIC COLORECTAL CANCER AFTER ANTI-VEGF THERAPY | 2024 |
|
RU2823505C1 |
METHOD FOR THE TREATMENT OF UNRESECTABLE HYLUS CHOLANGIOCARCINOMA | 2020 |
|
RU2755329C2 |
METHOD FOR ANALYSING PANCREATIC CANCER, METHOD FOR ANALYSING EXCISED COMPLEX OF ORGANS AND USING IT | 2014 |
|
RU2568766C2 |
Authors
Dates
2022-06-01—Published
2021-11-17—Filed